Medical Research News and Research

RSS

Wolters Kluwer Health partners with Egyptian Ministry of Higher Education and State Ministry for Scientific Research

Wolters Kluwer Health is pleased to announce a publishing partnership with the Egyptian Ministry of Higher Education and State Ministry for Scientific Research (ENSTINET). The two organizations have agreed to collaborate on the development and publication of leading medical and scientific journals and to help create a "Center of Excellence" in the region, bringing together the expertise of both parties.

29 Oct 2010

World's largest research initiative to mutate all mouse genes

The world's largest research initiative to mutate all mouse genes is now able to reach the summit because the ambitious EUCOMMTOOLS project started on October 1, 2010. This project is being coordinated by Helmholtz Zentrum München and will finalize the groundwork for the analysis of all mouse gene functions. The findings will contribute to a better understanding of the pathogenesis of widespread diseases such as Alzheimer's, depression, diabetes, chronic lung diseases or cancer.

28 Oct 2010

Lippincott Williams & Wilkins to publish journal Pathology

Lippincott Williams & Wilkins (LWW), part of Wolters Kluwer Health, announced today that it has signed an agreement to serve as exclusive publisher of Pathology effective January 1, 2011. The Royal College of Pathologists of Australasia (RCPA), which produces Pathology, is responsible for the training and professional development of pathologists and for the promotion of the science and practice of pathology.

27 Oct 2010

New type of radiation reduces GI side effects but does not improve survival rate in prostate cancer patients

A new British review of existing research suggests that while a newer type of radiation for the treatment of prostate cancer does not help patients live longer compared to an older type at least when similar doses are given it does appear to reduce gastrointestinal side effects.

27 Oct 2010

New strategic brand platform shows UPMC as world-class health care organization

UPMC (University of Pittsburgh Medical Center) today unveiled a new strategic brand platform "UPMC: Life Changing Medicine" and logo, unifying its clinical, insurance and international and commercial services activities with one consistent message.

26 Oct 2010

Combination of radiation and hormone therapy improves survival rate among prostate cancer patients

Prostate cancer patients who are treated with a combination of hormone therapy and radiation have a substantially improved chance of survival compared to patients who do not receive radiation, according to interim results of the largest randomized study of its kind presented at the plenary session, November 1, 2010, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO).

26 Oct 2010

Maven Semantic updates Lymphocyte Cell Biology research database

Maven Semantic announces updates to their Lymphocyte Cell Biology research database. The new database is now available to marketing, business development, competitor intelligence, KOL, medical affairs and related departments in the life sciences sector.

26 Oct 2010

GSN initiates trial of microarray PGD on pregnancy and implantation rates in IVF

Gene Security Network (GSN) announced today that it has initiated enrollment for a prospective randomized trial in collaboration with Ferring Pharmaceuticals to evaluate the impact of GSN's advanced preimplantation genetic diagnosis (PGD) with Parental Support™ on pregnancy and implantation rates in IVF.

25 Oct 2010

Non communicable diseases will cost India USD237 billion during 2006-15

Health experts participating at a roundtable organised by India Health Progress(IHP) on economic and social impact of non-communicable diseases in India are of the opinion that a concerted effort is required to address the growing burden.

25 Oct 2010

Childhood allergies and asthma linked to development in the womb

A child's chances of developing allergies or wheezing is related to how he or she grew at vital stages in the womb, according to scientists from the University of Southampton.

25 Oct 2010

Maven Semantic updates Antiviral research database

Maven Semantic announces updates to their Antiviral research database. The new database is now available to marketing, business development, competitor intelligence, KOL, medical affairs and related departments in the life sciences sector.

25 Oct 2010

New research shows flu virus with D222G mutation can cause pneumonia

A variant of last year's pandemic influenza linked to fatal cases carried a mutation that enabled it to infect a different subset of cells lining the airway, according to new research. The study, due to be published next week in the Journal of Virology, suggests that the mutant virus could have impaired the lungs' ability to clear out germs.

25 Oct 2010

Techulon signs license with Virginia Tech Intellectual Properties to market DNA delivery platform

Techulon Inc., a life sciences company based in the Virginia Tech Corporate Research Center, has signed an exclusive license with Virginia Tech Intellectual Properties Inc. to market a new, traceable DNA delivery platform created to deliver genetic medicine to cells while carrying a beacon so scientists can follow its progress.

22 Oct 2010

Paragon Bioservices awarded contract to assist USAMRIID in vaccine development efforts

Paragon Bioservices, a Baltimore-based CMO focused on the contract research, process development and manufacturing of biologics, announced today that it has been awarded a $4.99 million contract to assist the U.S. Army Medical Research Institute for Infectious Diseases in its vaccine development efforts.

22 Oct 2010

Morphotek receives DOD contract to support mAb therapies against pathogenic strains

Morphotek, Inc., a subsidiary of Eisai Inc., announced today that it has been awarded a contract for $2.5 million from the U.S. Department of Defense (DOD) to support the continuing development of monoclonal antibody (mAb) therapies against staphylococcal-derived toxins and pathogenic staphylococcal strains.

22 Oct 2010

Australian stem cell line offers fresh approach to diabetes cure

Australian researchers have developed the country’s first diabetes specific stem cell line, a major advance for patients suffering from the chronic disease.

21 Oct 2010

Research identifies key regulators that control transmission of malaria parasite

Scientists at The University of Nottingham and the Wellcome Trust Sanger Institute near Cambridge have pin-pointed the 72 molecular switches that control the three key stages in the life cycle of the malaria parasite and have discovered that over a third of these switches can be disrupted in some way.

21 Oct 2010

Protein IL-37 could help treat inflammatory diseases in adults and children

A husband and wife research team from Melbourne, Australia, have identified a protein that may be a key therapy for many inflammatory diseases, including those affecting premature babies.

21 Oct 2010

LSUHSC receives NIH grant for research on cancer and infectious diseases

LSU Health Sciences Center New Orleans has been awarded $12 million over five years by the National Institutes of Health to conduct research on diseases like prostate and stomach cancers, lymphoma and leukemia, dengue fever, tuberculosis, and herpes infections, as well as to support the development of academic research scientists.

21 Oct 2010

Researchers identify common link among malignant tumor types in all grades of cancer

Researchers from Mount Sinai School of Medicine, in collaboration with investigators of the National Institute of Health and Medical Research (INSERM) of France led by Nicolae Ghinea, PhD, have found a common link among several malignant tumor types in all grades of cancer. This breakthrough may ultimately provide a new diagnostic or therapeutic target to detect cancer early or stop tumor growth.

21 Oct 2010

Medical Research News and Research

Wolters Kluwer Health partners with Egyptian Ministry of Higher Education and State Ministry for Scientific Research

World's largest research initiative to mutate all mouse genes

Lippincott Williams & Wilkins to publish journal Pathology

New type of radiation reduces GI side effects but does not improve survival rate in prostate cancer patients

New strategic brand platform shows UPMC as world-class health care organization

Combination of radiation and hormone therapy improves survival rate among prostate cancer patients

Maven Semantic updates Lymphocyte Cell Biology research database

GSN initiates trial of microarray PGD on pregnancy and implantation rates in IVF

Non communicable diseases will cost India USD237 billion during 2006-15

Childhood allergies and asthma linked to development in the womb

Maven Semantic updates Antiviral research database

New research shows flu virus with D222G mutation can cause pneumonia

Techulon signs license with Virginia Tech Intellectual Properties to market DNA delivery platform

Paragon Bioservices awarded contract to assist USAMRIID in vaccine development efforts

Morphotek receives DOD contract to support mAb therapies against pathogenic strains

Australian stem cell line offers fresh approach to diabetes cure

Research identifies key regulators that control transmission of malaria parasite

Protein IL-37 could help treat inflammatory diseases in adults and children

LSUHSC receives NIH grant for research on cancer and infectious diseases

Researchers identify common link among malignant tumor types in all grades of cancer

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News